Expert Recall

Don’t Fall Victim to Product Labeling Errors
05-23-2011
Mike Rozembajgier Products can be recalled for all sorts of reasons, but one reason for withdrawals that in most cases can be easily prevented is product labeling errors. The product label is often the only connection between a consumer and a manufacturer. Information on the label includes ingredients and safety warnings, and if a label is misprinted, that communication error often results in a Class III recall.

Deloitte Survey Highlights Importance of Customer Communications
05-20-2011
Mike Rozembajgier The recently-released Deloitte LLP 2011 Consumer Food and Product Insights Survey opens a window into the minds of consumers and offers important insight into how they view the recall process and the current state of food safety. According to the survey, consumers are generally unfamiliar with food and consumer product safety regulations and want manufacturers to proactively communicate safety initiatives.

Expanded FDA Guidelines Allow Seizure of Food Processed in Unsafe Conditions
05-12-2011
Mike Rozembajgier The trend is clear. Over the past several years regulatory agencies such as the Consumer Protect Safety Commission (CPSC) and the Food and Drug Administration (FDA) have increased their oversight and authority to protect consumers. In yet another effort to flex its muscles and showcase its power, the FDA has passed two new rules that will further expand its regulatory oversight of the nation’s food supply.

FDA Recall Process Not Enough for Congress
05-09-2011
Howard Aughinbaugh This may go down in history as the year that Congress took a close look at the Food and Drug Administration (FDA)’s ability to keep consumers safe and then empowered the agency with tougher regulations and stricter enforcement authority. From food to pharmaceutical products to medical devices, recent Congressional inquiries into the FDA’s ability to protect consumers could lead to new regulations that affect how companies approach their recall management and navigate the complicated recall process.

Special Approval Not Enough to Deter Medical Device Recall Management
05-05-2011
Howard Aughinbaugh The U.S. Food and Drug Administration (FDA) may be next on the product safety hot seat. The Government Accountability Office (GAO) recently issued a report that found that some “high-risk” medical devices, including heart defibrillators and hip implants, have been approved for sale without being subject to the agency’s usual stringent oversight procedures. The FDA is also facing criticism over how it oversees recall management of defective devices. When the FDA is criticized for failing to appropriately manage recalls, you can expect that scrutiny to be quickly passed on to you as the manufacturer.